December 2025

Tartana Minerals has received $1 million from a new investor as part of a $1.275 million placement, setting the stage for debt reduction and upcoming shareholder decisions.

Neuren Pharmaceuticals has secured Health Canada approval to expand its pivotal Phase 3 trial of NNZ-2591 for Phelan-McDermid syndrome into Canadian sites, complementing ongoing US enrolment.

African Gold Limited has reported significant step-out drilling results at its Blaffo Guetto deposit in Côte d’Ivoire, extending gold mineralisation beyond previous estimates and reinforcing the project’s scale and potential under new Montage Gold ownership.

The Northern Finland Administrative Court has overturned Kingsrose Mining’s exploration permit for the Penikat Project due to procedural errors by the regulator, delaying planned drilling until at least April 2026. Kingsrose remains confident in the project’s long-term potential despite the setback.

Finbar Group has conditionally acquired a prime South Perth site for $16.5 million, aiming to launch a $350 million apartment development by 2028 and boosting its pipeline to over $1.6 billion.

Beetaloo Energy’s Carpentaria-5H well has delivered one of the highest gas flow rates in the Beetaloo Basin, showcasing promising long-term productivity and paving the way for pilot gas sales in 2026.

Kula Gold reports exceptional gold drill results extending over a 3km strike at Mt Palmer, while Forrestania Resources' takeover bid climbs beyond 73%. The company also completes maiden drilling at its Wozi Niobium Project, with assay results pending.

archTIS has renewed 1,000 NC Protect licenses within the U.S. Department of Defense’s Microsoft DoD365 environment and secured an $8 million debt facility to accelerate its U.S. market expansion.

Redcastle Resources has reported further high-grade and broad gold intercepts from its ongoing drilling at Redcastle Reef, reinforcing confidence in the deposit's geological continuity and supporting near-term mine planning.

Viridis Mining and Minerals has achieved a critical environmental milestone with the granting of the Preliminary License for its Colossus Rare Earth Project in Brazil, significantly de-risking the development timeline and paving the way for construction in 2026.

Midas Minerals has completed its acquisition of the Otavi Copper Project in Namibia, initiating multiple drilling programs across high-grade deposits and securing strong funding to drive exploration in 2026.

Regis Healthcare announces the resignation of CEO Dr Linda Mellors after six years, with a transition period underway as the board searches for her successor.

Comet Ridge Limited has obtained federal environmental approval for its Mahalo North natural gas project, paving the way for expanded development in Queensland’s Bowen Basin. This milestone complements recent ownership consolidation and state approvals, positioning the company to boost east coast gas supply.

Waypoint REIT has secured a decade-long lease extension with Viva Energy Australia on 21 sites, boosting rental income by over 12% from August 2026. The REIT also strengthens its financial footing through key refinancing moves.

Western Mines Group reports significant nickel sulphide mineralisation from deep diamond drilling at its Mulga Tank project, reinforcing its vision of a large-scale hybrid nickel system. Drilling will resume in January 2026 to extend these promising results.

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

Cyclopharm Limited has secured regulatory approval for its Technegas lung imaging technology in Colombia, marking its presence in 67 countries worldwide. This milestone aligns strategically with the upcoming global nuclear medicine congress in Cartagena.

Clarity Pharmaceuticals has secured positive FDA guidance to initiate a pivotal Phase III trial of its Cu-64 SARTATE diagnostic agent for neuroendocrine tumours, aiming to improve detection and patient outcomes.

Pure One Corporation Limited is set to exit its 40% stake in Turquoise Group for AUD 5 million, securing a substantial profit and refocusing on its core clean energy ventures.

Mithril Silver and Gold accelerates exploration at its Copalquin gold-silver project with a third drill rig mobilized and a 25,000-metre drilling program planned for 2026, targeting multiple high-grade zones.

BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics for US$4.8 billion includes Dimerix’s US licensing agreement, promising significant milestone payments and royalties. This deal strengthens Dimerix’s position as it advances its Phase 3 kidney disease therapy.

IVE Group has agreed to acquire Australian creative agency Daily Press for up to $35 million, bolstering its digital, social, and performance marketing capabilities as part of its ‘Now to 2030’ growth strategy.

Invictus Energy has completed the Petroleum Production Sharing Agreement process for its Cabora Bassa Project, setting the stage for significant gas exploration and development in Zimbabwe.

Lendlease has struck a binding agreement to sell a significant stake in its Malaysian TRX retail and office assets, marking a key step in its FY26 capital recycling strategy aimed at reducing gearing and unlocking value.